The combination is the first immune checkpoint inhibitor-based regimen to show a survival benefit for patients with platinum-resistant ovarian cancer.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/pembro-paclitaxel-approved-platinum-resistant-oc-2026a10004fs?src=rss
Author :
Publish date : 2026-02-11 23:04:00
Copyright for syndicated content belongs to the linked Source.
